Oakworth Capital Inc. Boosts Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Oakworth Capital Inc. raised its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 1.6% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 165,074 shares of the exchange traded fund’s stock after purchasing an additional 2,563 shares during the period. SPDR S&P Biotech ETF makes up approximately 1.2% of Oakworth Capital Inc.’s investment portfolio, making the stock its 20th biggest position. Oakworth Capital Inc.’s holdings in SPDR S&P Biotech ETF were worth $14,739,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in XBI. Macroview Investment Management LLC raised its stake in shares of SPDR S&P Biotech ETF by 7.8% in the 4th quarter. Macroview Investment Management LLC now owns 11,199 shares of the exchange traded fund’s stock valued at $1,000,000 after purchasing an additional 809 shares in the last quarter. Bison Wealth LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter valued at about $225,000. Strs Ohio raised its stake in shares of SPDR S&P Biotech ETF by 5.9% in the 4th quarter. Strs Ohio now owns 320,300 shares of the exchange traded fund’s stock valued at $28,599,000 after purchasing an additional 17,900 shares in the last quarter. Viewpoint Capital Management LLC raised its stake in shares of SPDR S&P Biotech ETF by 100.0% in the 4th quarter. Viewpoint Capital Management LLC now owns 2,000 shares of the exchange traded fund’s stock valued at $179,000 after purchasing an additional 1,000 shares in the last quarter. Finally, Capital Advisors Inc. OK acquired a new stake in SPDR S&P Biotech ETF during the fourth quarter worth about $234,000.

SPDR S&P Biotech ETF Trading Down 0.8 %

XBI traded down $0.67 on Wednesday, hitting $84.94. 9,694,925 shares of the company’s stock were exchanged, compared to its average volume of 11,681,729. The firm has a market cap of $6.60 billion, a PE ratio of 11.47 and a beta of 1.08. SPDR S&P Biotech ETF has a twelve month low of $63.80 and a twelve month high of $103.52. The stock has a fifty day moving average of $93.86 and a two-hundred day moving average of $84.12.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.